Core Scientific Q2 2024 Adj. EPS $(0.05) Misses $0.03 Estimate, Sales $141.102M Beat $128.574M Estimate
Portfolio Pulse from Benzinga Newsdesk
Core Scientific (NASDAQ:CORZ) reported Q2 2024 adjusted EPS of $(0.05), missing the $0.03 estimate by 266.67%. However, sales of $141.102M beat the $128.574M estimate by 9.74%, marking an 11.18% increase from the same period last year.
August 07, 2024 | 10:07 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Core Scientific reported a significant EPS miss but a notable sales beat for Q2 2024. The EPS of $(0.05) missed the $0.03 estimate by a wide margin, while sales of $141.102M exceeded expectations by 9.74% and grew 11.18% YoY.
The significant EPS miss is a negative indicator, but the strong sales beat and YoY growth provide a positive counterbalance. The mixed results are likely to result in neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100